Phase III randomized trial of IMPT versus IMRT for the treatment of head and neck oropharyngeal carcinoma (OPC)
Learn from Dr. Steven Frank as he discusses the results, challenges, and implications of the study "Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of head and neck oropharyngeal carcinoma (OPC)".
Learn More
Webinar
December 2023
White Paper
Popular in the community
Webinar
ISOP 2024
Case Study: Re-Irradiation
en
Webinar
ISOP 2024
Case Study: Prostate
Andrew
Lee
en
Webinar
ISOP 2024
Case Study: CNS & Leptomeningeal Disease
Minesh
Mehta
en
Webinar
ISOP 2024
Welcome to Beamtown - New Center Considerations
Helen
Shih
Shyam
Tanguturi
Ali
Onuralp
Thomas
Pevenage
Vincent
Collignon
en
Webinar
ISOP 2024
Beamtown - New Center Challenges | Planning
Helen
Shih
Darrin
Kistler
Thomas
Pevenage
Nick
Woulf
en
Webinar
ISOP 2024
Beamtown - New Center Challenges | Project Management
Helen
Shih
Mark
Pankuch
Minesh
Mehta
Fabian
Marechal
Vincent
Collignon
en
Webinar
ISOP 2024
Beamtown - New Center Challenges | Operations
Helen
Shih
Andrew
Lee
Craig
Stevens
James
Metz
Darrin
Kistler
Frederic
Genin
en
Webinar
Phase III randomized trial of IMPT versus IMRT for the treatment of head and neck oropharyngeal carcinoma (OPC)
An Interview with Dr. Steven Frank
Steven
Frank
en
Proton Therapy Publication
June 2024
Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT)
en